Ro-64-5781

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRo-64-5781
Drug Alias NameDHFR inhibitors (Roche)Ro-47-4352Ro-48-3706Ro-64-0234Ro-61-9175 +[8] 
ClassificationSmall molecules
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsStaphylococcal InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsStaphylococcal InfectionsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A